Le Lézard
Classified in: Health
Subject: CALENDAR OF EVENTS

Sienna Announces Fourth Quarter 2023 Results Release Date and Conference Call


MARKHAM, Ontario, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) announced that it will report its 2023 fourth quarter results after market close on Tuesday, February 20, 2024. Nitin Jain, President and Chief Executive Officer, and David Hung, Chief Financial Officer and Executive Vice President, will host a conference call for the investment community the following day, Wednesday, February 21, 2024 at 9:30 a.m. (ET).

The toll-free dial-in number for participants is 1-800-715-9871, conference ID: 6738823. A webcast of the call will be accessible via Sienna's website. The webcast of the call will be available for replay until February 20, 2025 and archived on Sienna's website.

About Sienna Senior Living

Sienna Senior Living Inc. (TSX:SIA) offers a full range of senior living options, including independent living, assisted living and memory care under its Aspira retirement brand, long-term care, and specialized programs and services. Sienna's approximately 12,000 employees are passionate about cultivating happiness in daily life. For more information, please visit www.siennaliving.ca.

For further information, please contact:
Nancy Webb
Senior Vice President, Public Affairs & Marketing
905-489-0788
[email protected]



These press releases may also interest you

at 07:35
ReCode Therapeutics Announces Appointment of Dean J. Mitchell as Chairman of Its Board of Directors
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today announced the appointment of Dean J. Mitchell as chairman of its Board of Directors....

at 07:35
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
Reneo Pharmaceuticals, Inc. and OnKure, Inc., a...

at 07:30
Spectral Medical Announces First Quarter Results and Provides Corporate Update
Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the first quarter ended March 31, 2024, and provided a...

at 07:30
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
Avicanna Inc. ("Avicanna" or "Company) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce the completion of...

at 07:30
Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
Moleculin Biotech, Inc., ("Moleculin" or the "Company"), a clinical stage pharmaceutical company...

at 07:30
Velocity National Provider Network Welcomes Local Infusion to Network, Making Affordable Infusion Therapy More Accessible
Velocity National Provider Network (VNPN) recently welcomed Local Infusion, an outpatient infusion therapy provider, to its care provider network as part of its ongoing work to expand access to top-tier healthcare services. Velocity National...

More news about Health...


News published on and distributed by: